Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2019 | 1 |
2022 | 1 |
2023 | 1 |
2024 | 1 |
Search Results
4 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Efficacy and Safety of the RBD-Dimer-Based Covid-19 Vaccine ZF2001 in Adults.
N Engl J Med. 2022 Jun 2;386(22):2097-2111. doi: 10.1056/NEJMoa2202261. Epub 2022 May 4.
N Engl J Med. 2022.
PMID: 35507481
Free PMC article.
Clinical Trial.
Immunogenicity and safety in healthy adults of full dose versus half doses of COVID-19 vaccine (ChAdOx1-S or BNT162b2) or full-dose CoronaVac administered as a booster dose after priming with CoronaVac: a randomised, observer-masked, controlled trial in Indonesia.
Fadlyana E, Setiabudi D, Kartasasmita CB, Putri ND, Rezeki Hadinegoro S, Mulholland K; BCOV21 study group.
Fadlyana E, et al.
Lancet Infect Dis. 2023 May;23(5):545-555. doi: 10.1016/S1473-3099(22)00800-3. Epub 2023 Jan 11.
Lancet Infect Dis. 2023.
PMID: 36640798
Clinical Trial.
Item in Clipboard
Xeno-free expansion of adult keratinocytes for clinical application: the use of human-derived feeder cells and serum.
Cheshire P, Zhafira AS, Banakh I, Rahman MM, Carmichael I, Herson M, Cleland H, Akbarzadeh S.
Cheshire P, et al. Among authors: zhafira as.
Cell Tissue Res. 2019 Jun;376(3):389-400. doi: 10.1007/s00441-018-02986-5. Epub 2019 Jan 21.
Cell Tissue Res. 2019.
PMID: 30666537
Item in Clipboard
Immunogenicity and Safety of Half-Dose Heterologous mRNA-1273 Booster Vaccination for Adults Primed with the CoronaVac® and ChAdOx1-S Vaccines for SARS-CoV-2.
Putri ND, Zhafira AS, Wicaksana P, Sinto R, Hanafi G, Wiyono L, Prayitno A, Karyanti MR, Naibaho ML, Febrina F, Sukandar H, Setiawaty V, Mursinah M, Putra AR, Wibowo H, Sundoro J, Satari HI, Oktavia D, Multihartina P, Harbuwono DS, Hadinegoro SR.
Putri ND, et al. Among authors: zhafira as.
Vaccines (Basel). 2024 Mar 22;12(4):344. doi: 10.3390/vaccines12040344.
Vaccines (Basel). 2024.
PMID: 38675727
Free PMC article.
Item in Clipboard
Cite
Cite